In vivo 13C-NMR evaluation of glycogen content in a patient with glycogen storage disease

J Inherit Metab Dis. 1992;15(5):723-6. doi: 10.1007/BF01800013.

Abstract

Glycogen storage disease was suspected in a 10-month-old boy. Initial technical problems did not permit the determination of the precise enzyme, deficiency, and type VI glycogen storage disease was only diagnosed at the age of 2 years. In the mean time, natural abundance 13C nuclear magnetic resonance evaluation of muscular and hepatic glycogen content indicated normal muscular glycogen and increased hepatic glycogen in our patient, a finding which strongly argued for the diagnosis of type VI glycogen storage disease. Even though the use of nuclear magnetic resonance might seem, in this situation, a somewhat circuitous means of reaching the diagnosis, it appears that nuclear magnetic resonance could provide a useful tool for a non-invasive diagnosis of glycogen storage diseases.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Creatine / blood
  • Glycogen / blood*
  • Glycogen Storage Disease / blood*
  • Glycogen Storage Disease / diagnosis
  • Glycogen Storage Disease Type V / blood
  • Glycogen Storage Disease Type V / diagnosis
  • Humans
  • Infant
  • Liver Glycogen / metabolism
  • Magnetic Resonance Spectroscopy
  • Male
  • Muscles / metabolism

Substances

  • Liver Glycogen
  • Glycogen
  • Creatine